"The voice for cancer physicians and their patients in Massachusetts."

Fellow and Young Clinician Support

In addition to all the other membership benefits, MSCO is investing in the future of oncology by supporting the professional development and research of young clinicians and Fellows.


MSCO Travel Awards

The Massachusetts Society of Clinical Oncology (MSCO) is pleased to announce that as part of our efforts to support the growth and future of the oncology profession, we will be providing a grant for oncology professionals from Massachusetts to travel to the ASCO Annual Meeting.

Among the recipients of the MSCO Travel Award will be one fellow of an ACGME-accredited training program and one young clinician (with less than five years of practice).

The application deadline is April 15

Download application and submission requirements


MSCO's ASCO Young Investigator AWARD

The Massachusetts Society of Clinical Oncologists (MSCO) is proud to annually fund one Young Investigator Award (YIA) for a qualified Massachusetts applicant through Conquer Cancer, the ASCO Foundation. We encourage all eligible Massachusetts Fellows and Trainees to apply. The YIA is a one-year, $57,500 grant that provides research funding to promising physicians to support their transition from final years of subspecialty training to faculty appointment and to encourage and promote quality research in clinical oncology. For questions about eligibility, please contact Conquer Cancer at grants@conquer.org


Past Award Recipients 

2022

A Phase 1 study of adding navitoclax to the combination of venetoclax and decitabine for advanced myeloid malignancies.

Evan Chen, MD a third year Hematology/Oncology fellow at the Dana-Farber Cancer Institute (DFCI). He is a clinical investigator-in-training who seeks to improve precision medicine for myeloid malignancies through the clinical trial development of novel therapeutics and the retrospective study of their real-world outcomes. He is currently helping to lead a phase I study of navitoclax added to the combination of venetoclax and hypomethylating agents for advanced myeloid malignancies. He recently joined the Division of Leukemia at DFCI.


2021

A Phase 2 trial of palbociclib in combination with axitinib and avelumab in metastatic clear cell renal cell carcinoma.

Praful Ravi, MBBChir, MRCP, a Medical Oncologist at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, is the recipient of the inaugural YIA Award supported by MSCO.


Quality and Innovation Grant

The purpose of the MSCO Quality & Innovation Grant is to improve the care of patients in the state of Massachusetts living with a diagnosis of cancer. Funding will be provided for an individual or a group seeking to improve the deliver of cancer care, the quality of cancer care, treatment of cancer, or comfort of patients suffering from cancer.

Past Grant Recipients

2019

Adapting the Electronic Patient Reported Outcomes (EPRO) Intervention to Improve Cancer Care Delivery and Clinical Outcomes of Limited-English Proficiency (LEP) Individuals Diagnosed with Advanced Gastrointestinal or Breast Cancer

Nadine McCleary, MD, MPH

2017

Oral Chemotherapy Management with Electronic Patient Reporting--A Community and Academic Hybrid Model 

Jessica Zerillo, MD, PhD and Meghan Shea, MD


A Bundle to Standardize Home Medication Administration and Reduce Errors in Pediatric Oncology Patients 

Chris Wong Quiles, MD, MPH, CPPS


2015

Feasibility, acceptability and effectiveness of the MBSR for smoking cessation in cancer patients

Marjory Charlot, MD, MPH, MSc




Massachusetts Society of Clinical Oncologists ©2023

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329  |  email: msco@mms.org

Powered by Wild Apricot Membership Software